Skip to main content
Log in

Letter to the Editor: Comment on: “LI‑RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection”

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Zhang C, Yang R, Wang X, Tao Y, Tang S, Tian Z, Zhou Y. LI-RADS morphological type predicts prognosis of patients with hepatocellular carcinoma after radical resection. Ann Surg Oncol. 2023;30(8):4876–85. https://doi.org/10.1245/s10434-023-13494-4.

    Article  PubMed  Google Scholar 

  2. Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, Imbriani S, Claar E, Cozzolino D, Sasso FC, Marrone A, Adinolfi LE, Rinaldi L. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol. 2023;29(8):1243–60. https://doi.org/10.3748/wjg.v29.i8.1243.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Chan AWH, Zhong J, Berhane S, Toyoda H, Cucchetti A, Shi K, Tada T, Chong CCN, Xiang BD, Li LQ, Lai PBS, Mazzaferro V, Garcia-Finana M, Kudo M, Kumada T, Roayaie S, Johnson PJ. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol. 2018;69(6):1284–93. https://doi.org/10.1016/j.jhep.2018.08.027.

    Article  PubMed  Google Scholar 

  4. Zhang W, Zhang B, Chen XP. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Front Med. 2021;15(2):155–69. https://doi.org/10.1007/s11684-021-0848-3.

    Article  PubMed  Google Scholar 

  5. Huang G, Li PP, Lau WY, Pan ZY, Zhao LH, Wang ZG, Wang MC, Zhou WP. Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA Levels: a randomized controlled trial. Ann Surg. 2018;268(6):943–54. https://doi.org/10.1097/SLA.0000000000002727.

    Article  PubMed  Google Scholar 

  6. Wang Z, Ren Z, Chen Y, Hu J, Yang G, Yu L, Yang X, Huang A, Zhang X, Zhou S, Sun H, Wang Y, Ge N, Xu X, Tang Z, Lau W, Fan J, Wang J, Zhou J. Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study. Clin Cancer Res. 2018;24(9):2074–81. https://doi.org/10.1158/1078-0432.CCR-17-2899.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funding.

Author information

Authors and Affiliations

Authors

Contributions

QR: conceptualization, original draft, project administration. YW: writing, review and editing.

Corresponding author

Correspondence to Yanjun Wang MD.

Ethics declarations

Disclosure

The authors disclose no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ren, Q., Wang, Y. Letter to the Editor: Comment on: “LI‑RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection”. Ann Surg Oncol 30, 8023–8024 (2023). https://doi.org/10.1245/s10434-023-14444-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14444-w

Navigation